Previous 10 | Next 10 |
agilon health inc. (AGL) is expected to report $-0.05 for Q3 2023
2023-11-01 16:04:27 ET More on agilon health agilon health: Improved Member Growth And Economies of Scale May Imply Undervaluation agilon health: Strong Sales Growth, Lacks Remaining Value Drivers agilon health, inc. (AGL) Q2 2023 Earnings Call Transcript See...
Sale of MDX Hawaii enables agilon to focus on its full-risk partnership model in core partner markets agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has sold MDX Hawaii, a wholly owned subsidiar...
RESEARCH DEMONSTRATES POTENTIAL OF THE PARSORTIX SYSTEM TO SUPPORT POWERFUL CHARACTERISATION OF CTCS IN HEAD AND NECK CANCER 41 key biomarkers including the immune checkpoint proteins PD-L1, CTLA4 and CD39 successfully evaluated Providing key information which could support the developm...
agilon REACH ACOs achieved $107 million in gross savings and 99.8% quality score agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $107 million in gr...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2023 after the market closes on Thursday, November 2, 2023, and host a conference call at 4:30 PM East...
2023-09-13 23:31:44 ET Summary agilon health expects positive adjusted EBITDA in 2023 and is experiencing double-digit net sales growth. The company's growth is driven by an increase in the number of members and partnerships with local physicians. Economies of scale, marketing...
2023-09-13 18:00:00 ET Summary The company's stock has been on a volatile journey since December, currently selling at previous lows. A secondary offering of common shares by a selling stockholder saw the market react violently. Despite solid performance, via growth in sales a...
Interim Results for the six months ended 30 June 2023 BUILDING COMMERCIAL MOMENTUM DELIVERS REVENUE GROWTH Cash runway extended into Q1 2025 GUILDFORD, SURREY / ACCESSWIRE / September 7, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative ...
2023-08-04 16:27:09 ET agilon health, inc. (AGL) Q2 2023 Earnings Conference Call August 03, 2023 04:30 PM ET Company Participants Matthew Gillmor - Vice President, Investor Relations Steve Sell - Chief Executive Officer Tim Bensley - Chief Financial Officer ...
News, Short Squeeze, Breakout and More Instantly...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Easter...
Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon’s Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced ...
2024-07-07 00:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...